Dr. Cindy Iris Varga, MD

Dr. Varga practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Varga's NPI, 1043555139, was assigned on November 30, 2012. Dr. Varga holds North Carolina license 2021-02866.

Dr. Varga's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Varga's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. Dr. Varga is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Atrium Health Levine Cancer Institute. Dmand AI also links Dr. Varga to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varga practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Varga's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Varga is licensed in North Carolina.

CMS data shows 231 Medicare services from Dr. Varga across 4 procedure codes in 2024, all of them office visits, for 106 Medicare patients. Medicare paid $17,342 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 106 Medicare patients who saw Dr. Varga in 2024. The largest group is 65 to 74, with 61 patients. 69% of them have high blood pressure, and 64% have high cholesterol. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Varga's median patient age at 72, with 45% women.

In 2024, Dr. Varga wrote 466 Medicare Part D claims for 75 patients. 80% of them were for generic drugs. CMS names the drug for 279 of them, across 10 drugs with 11 or more claims each, at $565,325 in total drug cost. In 2023, CMS named 310 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Varga for performance year 2024, reported as part of a group. Dr. Varga accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Varga as offering telehealth.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 45 papers to Dr. Varga, published from 2013 to 2025. 2018 was the busiest year, with 9. The most frequent topics are Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis and Amyloidosis. Dr. Varga has published most often in Clin Lymphoma Myeloma Leuk. Dr. Varga's most frequent co-authors are Raymond L. Comenzo, MD, Manisha Bhutani, MD and Amandeep Godara, MD.

Dmand AI links Dr. Varga to 4 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Immunoglobulin Light-chain Amyloidosis, Amyloidosis and Multiple Myeloma.

CMS Open Payments shows 31 general payments to Dr. Varga from 8 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 94% of the total. Janssen Pharmaceuticals, Inc paid the most, $9,671.